Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
4.900
-0.130 (-2.58%)
At close: Jun 27, 2025, 4:00 PM
4.950
+0.050 (1.02%)
After-hours: Jun 27, 2025, 7:48 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $245.50 million as of June 27, 2025. Its market cap has increased by 9.28% in one year.
Market Cap
245.50M
Enterprise Value
164.25M
1-Year Change
9.28%
Ranking
Category
Stock Price
$4.90
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $245.50M, an increase of 10.39%. That is a compound annual growth rate of 2.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 245.50M | -33.41% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 716.87B |
| Johnson & Johnson | 366.18B |
| AbbVie | 329.98B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 276.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.95B |
| AstraZeneca | 215.99B |